Data Characteristics for This Category
Market access regulation data in the biopharmaceutical industry primarily originates from regulatory bodies (e.g., US FDA, European EMA, China NMPA). This includes regulations, guidelines, approval documents, national medical insurance catalogs, and pharmacoeconomic evaluation reports. Update frequency varies by country policy changes, new drug approvals, and insurance negotiations. Updates are typically quarterly or annually, but critical regulatory changes can occur at any time. Document structures are mostly unstructured text, including legal texts in PDF, guidelines in Word, and policy interpretations on web pages. Specific fields and units include extensive medical terminology, pharmaceutical names, clinical trial data, reimbursement codes (e.g., ICD-10, DRG/DIP), and complex descriptions of approval process nodes.
Constraints Imposed by These Characteristics on Deployment and Upgrade
The unstructured nature and frequent updates of market access regulation data present deployment challenges for FastGPT. First, a large volume of PDF and Word documents requires efficient text extraction and cleaning to ensure knowledge base accuracy. Second, frequent policy updates necessitate incremental update and version management mechanisms to prevent duplicate data ingestion and confusion with outdated policies. Additionally, documents containing specific medical and pharmaceutical fields require the model to have strong semantic understanding to accurately answer queries involving specialized terminology. Deployment must consider text segmentation strategies for long regulatory texts. During upgrades, seamless integration of new and old knowledge is crucial to avoid deviations in Q&A logic caused by model or configuration updates.
Configuration Strategy
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 1000 MB | Market access regulatory documents are often large; this ensures full document upload. |
maxContext | 8192 token | Regulatory texts frequently contain complex logic and extensive details, requiring a longer context window. |
Chunk size | 800 characters | Accommodates the integrity of regulatory clauses, preventing truncation of critical information. |
Recall count | Top 8 entries | Increases coverage of relevant regulatory clauses for complex questions. |
Similarity threshold | Calibrate based on testing | Balances recall and accuracy based on actual query performance, e.g., 0.75. |
Rerank result count | Top 3 entries | Ensures the most relevant core clauses are prioritized, improving answer precision. |
Three Common Mistakes
- Q&A results still cite old policy terms after a knowledge base update: This happens when incremental updates or version management are not executed correctly, leading to a mix of new and old data.
ModuleNotFoundErroron startup after deploying local source code: This usually indicates incomplete dependency installation or incorrect environment configuration.- Querying specific drug reimbursement scope returns empty or inaccurate results: This may be due to overly fine-grained text segmentation, which splits critical fields (e.g., drug names, reimbursement codes), preventing the model from making effective associations.
How to Verify Correct Configuration
- Upload the latest medical insurance catalog file. Verify that all drug names and reimbursement categories are correctly indexed and searchable.
- For a revised regulation, use both old and new versions of the content to ask questions. Confirm the model can accurately distinguish and cite the currently effective terms.
- Submit questions containing complex medical terminology and procedural steps. Check if the Q&A results accurately pinpoint relevant regulatory clauses and provide clear explanations.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.